The Trump administration abandoned its proposal to overhaul the drug rebate system this week, but a host of other high-profile proposals to lower drug prices remain.
Pharmacy
United Health Services Retail Pharmacy at Binghamton (N.Y.) General Hospital is using an automatic pill dispenser to free up pharmacist time, according to Fox affiliate WICZ.
Christi Shaw, Eli Lilly's president of biomedicines, will step down from her role in August, the drugmaker announced July 11.
Amneal Pharmaceuticals, a New Jersey generic drugmaker will close its factory in Hauppauge, N.Y., next year, eliminating 220 jobs, according to Newsday.
Reckitt Benckiser Group, a U.K. consumer goods company, will pay $1.4 billion to resolve allegations that the company profited by deceiving healthcare providers about the safety of its opioid-addiction treatment, according to The Wall Street Journal.
Advertisement
Kirby Medical Center in Monticello, Ill., plans to open a retail pharmacy on its campus, according to the Journal-Republican.
Medicare Advantage insurer Clover Health is launching a subsidiary that will develop medications for elderly patients with chronic conditions.
CVS Health plans to open HealthHubs in several new markets next year that are expected to have higher populations of chronic disease patients, according to CNBC.
The Trump administration abandoned a controversial proposal that would have overhauled the rebate system, according to The Hill.
Patients and pharmacists nationwide are grappling with a persistent shortage of Mylan's EpiPen, forcing some to travel great distances or go through several hoops to access the lifesaving allergy treatment, according to Bloomberg.